SBH
AHCO icon

Segall Bryant & Hamill’s AdaptHealth AHCO Stock Holding History

Segall Bryant & Hamill’s Portfolio AHCO Stock Details AHCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$33.5M Sell
3,219,417
-259,175
-7% -$2.89M 0.4% 62
2026
Q1 		$41.4M Sell
3,478,592
-445,927
-11% -$4.56M 0.59% 34
2025
Q4 		$39.1M Sell
3,924,519
-374,571
-9% -$3.58M 0.53% 38
2025
Q3 		$38.5M Sell
4,299,090
-383,283
-8% -$3.55M 0.51% 44
2025
Q2 		$44.2M Sell
4,682,373
-71,433
-2% -$630K 0.62% 28
2025
Q1 		$51.5M Sell
4,753,806
-50,175
-1% -$505K 0.79% 11
2024
Q4 		$45.7M Buy
4,803,981
+1,102,173
+30% +$11.2M 0.63% 32
2024
Q3 		$41.6M Buy
3,701,808
+496,453
+15% +$5.28M 0.57% 38
2024
Q2 		$32.1M Buy
3,205,355
+789,288
+33% +$8.02M 0.57% 42
2024
Q1 		$27.8M Sell
2,416,067
-46,716
-2% -$397K 0.52% 56
2023
Q4 		$18M Buy
2,462,783
+335,087
+16% +$2.64M 0.35% 98
2023
Q3 		$19.4M Buy
2,127,696
+774,951
+57% +$9.29M 0.22% 125
2023
Q2 		$16.5M Buy
+1,352,745
New +$15.1M 0.17% 156

Other funds holding AHCO

OCA
OEP Capital Advisors New York $170M AUM 10.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SC
SkyKnight Capital San Francisco, California $94.1M AUM 10.85% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
RP
Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Segall Bryant & Hamill's AHCO Position: Q2 2026 in Review

Segall Bryant & Hamill reduced its AdaptHealth (AHCO) stake by 7.5% in Q2 2026, selling an estimated $2.89M and leaving 3,219,417 shares worth $33.5M. The position accounts for 0.4% of the portfolio, ranked #62.

Segall Bryant & Hamill first reported a position in AHCO in Q2 2023 and has held it in 13 quarters since. The position peaked at $51.5M in Q1 2025. 238 funds tracked by Wall St. Rank hold AHCO as of Q2 2026.

  • Segall Bryant & Hamill held 3,219,417 shares of AdaptHealth worth $33.5M as of Q2 2026.
  • Segall Bryant & Hamill sold 259,175 AdaptHealth shares in Q2 2026, an estimated $2.89M.
  • AdaptHealth made up 0.4% of Segall Bryant & Hamill's portfolio in Q2 2026, its #62 holding.
  • Segall Bryant & Hamill first reported a position in AdaptHealth in Q2 2023 and has held it in 13 quarters since.
  • Segall Bryant & Hamill's AdaptHealth position peaked at $51.5M in Q1 2025.
  • 238 funds tracked by Wall St. Rank held AdaptHealth as of Q2 2026.

Based on Segall Bryant & Hamill's 13F filing for Q2 2026, filed 12 Aug 2026.